CSX vs PPCB · P/E 19, rev $14.09B vs P/E 0.0, $3.9M cap
CSX Corporation (CSX) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
CSX Corporation (CSX) is a railroads company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported CSX revenue for 2025-12-31 was $14.09B. Net income was $2.89B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
PPCB does not have a complete income-statement cache yet.
CSX currently screens at market cap $61.18B and trailing P/E 19.4. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the CSX and PPCB stock pages for the full models.
Not investment advice.